Blood Biomarker Discovery

We use our Nanoomics Technology platform in order to discover molecular biomarkers in blood (using both preclinical models and human clinical samples), for a range of diseases and biomarker applications with an emphasis on the early detection of cancer and neurodegenerative diseases.